Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSXU9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,718
Award facts
- Contract value 100% obligated
- $18,718.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Dupixent 300 mg/2 mL pen injections, with final delivery required by January 12, 2026. This delivery order is a non-set-aside, competitively awarded contract and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That master IDC, valued at up to $999.9M through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered.
Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps in military beneficiaries and veterans. AmerisourceBergen Drug Corp, as the child entity of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities worldwide. The firm fixed-price structure and rapid completion timeline indicate this is a routine replenishment order fulfilling immediate pharmaceutical supply needs within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FSXU9?
SPE2DR26FSXU9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FSXU9 worth?
The government has obligated $18,718 on SPE2DR26FSXU9.
Is contract SPE2DR26FSXU9 an order under another contract?
Yes. SPE2DR26FSXU9 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSXU9 competed?
The extent of competition for SPE2DR26FSXU9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award